Encountering unpredicted off-target effects of pharmacological inhibitors
Open Access
- 9 May 2011
- journal article
- comment
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 150 (1), 1-3
- https://doi.org/10.1093/jb/mvr053
Abstract
With the emergence of chemical biology, the use of pharmacological inhibitors in biological research has been expanding. SP600125 is a low-molecular weight compound that has been widely used to inhibit c-Jun-N-terminal kinase (JNK). A recent publication by Tanemura et al. (J. Biochem. 145:345–354, 2009) indicated that SP600125 also inhibits phosphatidylinositol 3-kinase (PI3K) in an isoform-selective fashion: it efficiently inhibited the delta isoform of p110 catalytic subunit (p110δ), which is primarily expressed in leucocytes, but neither of the ubiquitously expressed isoforms, p110α and p110γ. Here, I discuss what we learn from such unpredicted off-target effects of pharmacological inhibitors.Keywords
This publication has 15 references indexed in Scilit:
- Drug discovery and development focusing on existing medicines: drug re-profiling strategyThe Journal of Biochemistry, 2011
- Diverse Physiological Functions of MKK4 and MKK7 during Early EmbryogenesisThe Journal of Biochemistry, 2010
- Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulationBiochemical Journal, 2009
- Blockage by SP600125 of Fc Receptor-Induced Degranulation and Cytokine Gene Expression in Mast Cells is Mediated Through Inhibition of Phosphatidylinositol 3-Kinase Signalling PathwayThe Journal of Biochemistry, 2008
- A quantitative analysis of kinase inhibitor selectivityNature Biotechnology, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and AngiogenesisCancer Research, 2004
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemiasJournal of Medicinal Chemistry, 1987